Chinese Expert Consensus on Standardized Treatment for Presacral Cysts (2023)
Title: Chinese expert consensus on standardized treatment for presacral cysts
Published: February 21, 2023
Journal: Gastroenterology Research and Practice (Gastroenterol Rep (Oxf))
Developed by: Chinese General Surgery Expert Group; Cancer Prevention and Treatment Expert Committee, Cross-Straits Medicine Exchange Association; Committee of Combined Viscerectomy and Quality Control, Colorectal Cancer Committee of Chinese Medical Doctor Association
Corresponding authors: Gangcheng Wang (Zhengzhou University Affiliated Cancer Hospital), Chengli Miao (Peking University International Hospital)
Abstract
Presacral cysts are cystic or cyst–solid lesions located between the sacrum and rectum, closely involving adjacent pelvic floor structures (sacrococcygeal fascia, rectum, anal sphincter). Most are benign, arising from aberrant embryogenesis (tailgut, neurenteric canal, primitive streak). Surgical resection is the mainstay; incomplete resection leads to inevitable recurrence and intractable sacrococcygeal sinuses. This consensus standardizes diagnosis, surgical approaches, and perioperative management to improve outcomes.
1. Origin and Pathology
Etiology
-
Derived from incompletely degenerated embryonic structures: tailgut, neurenteric canal, primitive streak.
-
Tailgut cysts (most common): polycystic, lined with gastrointestinal epithelium; contain clear/yellowish viscous fluid.
Classification
-
Benign: Epidermoid cyst, dermoid cyst, enteric cyst (tailgut cyst, cystic rectal duplication), neurenteric cyst, teratoma.
-
Malignant: Rare; may arise from malignant transformation of benign cysts.
2. Diagnosis
Clinical Manifestations
-
Asymptomatic (incidental finding) or nonspecific: sacrococcygeal pain, defecation dysfunction, perianal mass, recurrent infection.
-
Malignant features: intractable pain, bone destruction, invasion of adjacent organs.
Imaging
-
MRI (gold standard): Defines cyst location, size, relationship to sacrum/rectum/sphincter; distinguishes benign vs. malignant.
-
CT: Evaluates bone involvement and calcification.
-
Ultrasound: Initial screening; transrectal/transperineal for deep lesions.
Biopsy
-
Routine needle biopsy not recommended (risk of infection/sinus formation).
-
Biopsy only for suspected malignancy (intractable pain, bone destruction, MRI invasion) to guide treatment.
3. Surgical Principles
Core Goal
Complete en bloc resection of the cyst wall to prevent recurrence; avoid piecemeal removal.
Indications for Surgery
-
Symptomatic cysts (pain, defecation disorder, infection).
-
Asymptomatic cysts >3 cm or growing.
-
Suspected malignant transformation.
Contraindications
-
Severe comorbidities precluding surgery.
-
Benign, small, asymptomatic cysts in elderly/frail patients.
4. Surgical Approaches (Recommended)
Transperineal Approach (Preferred for Low Cysts)
-
Longitudinal incision: For cysts with upper pole <S4; jackknife position; incision along gluteal sulcus; resect coccyx for exposure.
-
Transverse arc incision: For larger low cysts; coccyx as landmark; better exposure for eccentric lesions.
-
Intersphincteric incision: For cysts adjacent to anal canal; preserves sphincter function.
Transabdominal Approach
-
For high cysts (upper pole >S4) or large/complex lesions; laparotomy or laparoscopy; mobilize rectum, dissect presacral space.
Combined Transabdominal–Transperineal Approach
-
For giant, multilocular, or recurrent cysts; optimal exposure for complete resection.
Key Technical Points
-
Preserve Waldeyer fascia and presacral fascia to avoid nerve/vessel injury.
-
Protect sacral nerves (S3–S5) to prevent incontinence/sexual dysfunction.
-
For cyst–rectal fistula: resect fistula tract; use gluteal muscle flap for repair; avoid routine diverting stoma.
5. Perioperative Management
Preoperative
-
Bowel preparation; broad-spectrum antibiotics; MRI for surgical planning.
-
Multidisciplinary discussion (surgery, gynecology, orthopedics, radiology, pathology) for complex cases.
Intraoperative
-
Frozen section for suspected malignancy; extend resection if malignant.
-
Hemostasis: preserve middle sacral artery; use electrocautery/hemostatic agents.
Postoperative
-
Drainage: closed suction for 3–5 days; monitor for infection/hematoma.
-
Complications:
-
Infection: Antibiotics; debridement if abscess.
-
Fecal incontinence: Pelvic floor rehabilitation; sacral nerve stimulation if severe.
-
Recurrence: Re-resection with wider margins.
6. Follow-Up
Benign Cysts
-
Every 6 months for 2 years; annually thereafter.
-
Imaging: MRI/CT/ultrasound to detect recurrence.
Malignant Cysts
-
Every 3 months for 2 years; every 6 months thereafter.
-
Multidisciplinary adjuvant therapy (radiation/chemotherapy) as indicated.
7. Key Recommendations
-
Complete resection is mandatory for cure; avoid incomplete removal.
-
MRI is essential for preoperative planning.
-
Transperineal approach is first-line for low cysts; transabdominal for high lesions.
-
Preserve sacral nerves and sphincter to maintain function.
-
Multidisciplinary care improves outcomes for complex/malignant cases.